Alternative Treatment for Insomnia in Adults Request More Information Trial Objective We are studying an experimental therapy for the treatment of insomnia in adults. Adults ages 21 and older with chronic insomnia who have taken sleep medication (such as Ambien or sedative hypnotics) for more than one year are needed for this sleep clinical trial. This trial looks at how to help insomnia patients transition from sleep medication to other treatment options such as CBT and hypnotic tapering. Study participation involves insomnia therapy and supervised medication taper at no cost. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults 21 years of age and older who have chronic insomnia, who currently use medication to treat chronic insomnia (used for 12 or more months) and who want to stop using this medication. Age: 21+ Gender: Any Gender Estimated Time Commitment Up to 15 visits to our sleep clinic over a 12-month period × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Rachel Johnson 303.398.1058 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institutes of Health Principal Investigators Jack Edinger, PhD + × Jack Edinger, PhD Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Sleep Medicine View Full Profile Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective We are studying an experimental therapy for the treatment of insomnia in adults. Adults ages 21 and older with chronic insomnia who have taken sleep medication (such as Ambien or sedative hypnotics) for more than one year are needed for this sleep clinical trial. This trial looks at how to help insomnia patients transition from sleep medication to other treatment options such as CBT and hypnotic tapering. Study participation involves insomnia therapy and supervised medication taper at no cost.